Evidence map›Paper›PMID 36937864›Full record

ArticleFrontiers in pharmacology2023

Risk factors, clinical correlates, and social functions of Chinese schizophrenia patients with drug-induced parkinsonism: A cross-sectional analysis of a multicenter, observational, real-world, prospective cohort study.

Jiajun Weng, Lei Zhang, Wenjuan Yu, Nan Zhao, Binggen Zhu, Chengyu Ye, Zhanxing Zhang, Changlin Ma, Yan Li, Yiming Yu and 1 more

Open access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Jiajun WengShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Lei ZhangShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wenjuan YuShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Nan ZhaoShanghai Pudong District Mental Health Center, Shanghai, China.
Binggen ZhuShanghai Pudong District Mental Health Center, Shanghai, China.
Chengyu YeShanghai Zhongshan Hospital, Shanghai, China.
Zhanxing ZhangShanghai Clinical Research Center for Mental Health, Shanghai, China.
Changlin MaShanghai Jiading District Mental Health Center, Shanghai, China.
Yan LiShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yiming YuShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Huafang LiShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shanghai Jiao Tong University · CNShanghai Mental Health Center · CNJiading District Central Hospital · CNZhongshan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antipsychoticsdrug-induced parkinsonismmood stabilizerschizophreniaside effects

Identifiers

PMID36937864
PMCPMC10020528
OpenAlexW4323045640

What Socratic holds

Textfull text, public
LicenceCC BY
measurements read95
reference markers read2
identifiers read2
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.